The GCCTI project team, with advice from the Scientific Steering Group (SSG), supports researchers across Australia to generate, propose, and develop concepts for trials of molecularly-targeted treatments suitable for grant applications seeking funding through nationally competitive schemes.
The GCCTI is supported by a national SSG which includes representation from individuals with scientific, clinical, and methodological expertise to inform the direction of the initiative.
Chair
- Professor Martin Stockler, Oncology Co-Director, NHMRC CTC
Members
- Prof Steve Ackland, Director – Senior Staff Specialist in Medical Oncology, Calvary Mater Newcastle Hospital; Professor, Faculty of Health and Medicine, University of Newcastle
- A/Prof Richard De Abreu Lourenco, Associate Professor, Centre for Health Economics Research and Evaluation (CHERE), University of Technology Sydney
- Prof Anna DeFazio, Sydney West Chair of Translational Cancer Research, Centre of Cancer Research (The University of Sydney)
- Dr Alex Dobrovic, Translational Genomics & Epigenomics Laboratory (Olivia Newton-John Cancer Research Institute)
- Dr Craig Gedye, Medical Oncologist, Calvary Mater Newcastle
- Dr Andrew Haydon, Medical Oncologist (Alfred Health)
- Dr Kirsten Hogg, Walter and Eliza Hall Institute of Medical Research
- Dr Ivan Ho Shon, Senior Staff Specialist, Department of Nuclear Medicine and PET (Prince of Wales Hospital), Conjoint Senior Lecturer (University of New South Wales), The Australasian Radiopharmaceutical Trials Network (ARTnet)
- Dr Kate Mahon, Medical Oncologist (Chris O’Brien Lifehouse, Sydney; Medical Oncologist and Royal Prince Alfred Hospital)
- Prof Michael Millward, Cancer Council Professor of Clinical Cancer Research (University of Western Australia), Consultant Medical Oncologist (Linear Clinical Research), Adjunct Professor (School of Medical and Health Sciences, Edith Cowan University)
- Prof Andrew Redfern, Clinical Academic Oncologist and Haematology-Oncology Discipline Lead (University of Western Australia), Medical Oncologist (South Metropolitan Health Service), Medical Director (Linear Clinical Research), Associate Director (Harry Perkins Institute of Medical Research), and Lead Clinician, Breast Tumour Collaborative (WA Cancer & Palliative Care Network)
- A/Prof Clare Scott, Medical Oncologist and Laboratory Head, Stem Cells and Cancer Division (Walter and Eliza Hall Institute)
- Dr William Stevenson, Clinical Haematologist (Royal North Shore Hospital)
- John Stubbs, CanSpeak
Expert working groups will be established for new concepts selected for development into proposals. The working groups will be formed on an as needed basis, and will draw members from the project team, Scientific Steering Group, and other experts as required (such as quality of life and economics expertise). The working groups will provide content knowledge, expertise, and input required to develop high quality proposals for grant submissions.
NHMRC CTC
- Prof Martin Stockler (Chair)
- Dr Belinda Kiely
- Dr Ben Kong
- Dr Chee Lee
- Dr Yeh Chen Lee
- Prof John Simes
- Dr Katrin Sjoquist
- Dr Yu Yang Soon
- Dr Angelina Tjokrowidjaja
- Dr Sonia Yip
- Ms Kirston Barton
Zest
- Katie Barwell
- Helena Knezevic
- Justine Lau